Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $250
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Patrick Moley maintains an Overweight rating on CME Group (NASDAQ:CME) and raises the price target from $240 to $250.
October 28, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has maintained an Overweight rating on CME Group and increased the price target from $240 to $250, indicating a positive outlook.
The increase in price target from $240 to $250 by Piper Sandler suggests a positive outlook for CME Group, likely leading to a short-term price increase. The Overweight rating indicates confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100